The role of non-P450 enzymes in drug oxidation

被引:58
作者
Beedham, C [1 ]
机构
[1] Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England
来源
PHARMACY WORLD & SCIENCE | 1997年 / 19卷 / 06期
关键词
drug oxidation; non-P450; enzymes; prodrug activation; flavin monooxygenase; monoamine oxidase; aldehyde dehydrogenase; aldehyde oxidase; xanthine oxidase;
D O I
10.1023/A:1008668913093
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In addition to cytochrome P450, oxidation of drugs and other xenobiotics can also be mediated by non-450 enzymes, the most significant of which are flavin monooxygenase, monoamine oxidase, alcohol dehydrogenase, aldehyde dehydrogenase, aldehyde oxidase and xanthine oxidase. This article highlights the importance of these non-P450 enzymes in drug metabolism. A brief introduction to each of the non-P450 oxidizing enzymes is given in this review and the oxidative reactions have been illustrated with clinical examples. Drug oxidation catalyzed by enzymes such as flavin monooxygenase and monoamine oxidase may often produced the same metabolites as those generated by P450 and thus drug interactions may be difficult to predict without a clear knowledge of the underlying enzymology, in contrast, oxidation via aldehyde oxidase and xanthine oxidase gives different metabolites to those resulting from P450 hydroxylation. Although oxidation catalyzed by non-P450 enzymes can lead to drug inactivation, oxidation may be essential for the generation of active metabolite(s). The activation of a number of prodrugs by non-P450 enzymes is thus described. It is concluded that there is still much to learn about factors affecting the non-P450 enzymes in the clinical situation.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 103 条
[1]  
ACHEAMPONG AA, 1995, DRUG METAB DISPOS, V23, P708
[2]   PHARMACOGENETICS OF ALCOHOL METABOLISM AND ALCOHOLISM [J].
AGARWAL, DP ;
GOEDDE, HW .
PHARMACOGENETICS, 1992, 2 (02) :48-62
[3]  
[Anonymous], 1980, ENZYMATIC BASIS DETO
[4]  
AYESH R, 1988, BRIT J CLIN PHARMACO, V25, pP664
[5]   THE FISH ODOR SYNDROME - BIOCHEMICAL, FAMILIAL, AND CLINICAL ASPECTS [J].
AYESH, R ;
MITCHELL, SC ;
ZHANG, A ;
SMITH, RL .
BRITISH MEDICAL JOURNAL, 1993, 307 (6905) :655-657
[6]  
Beedham C, 1995, PROG BRAIN RES, V106, P345
[7]  
Beedham C, 1987, Prog Med Chem, V24, P85, DOI 10.1016/S0079-6468(08)70420-X
[8]  
BEEDHAM C, 1992, DRUG METAB DISPOS, V20, P889
[9]   SUBSTRATE-SPECIFICITY OF HUMAN LIVER ALDEHYDE OXIDASE TOWARD SUBSTITUTED QUINAZOLINES AND PHTHALAZINES - A COMPARISON WITH HEPATIC ENZYME FROM GUINEA-PIG, RABBIT, AND BABOON [J].
BEEDHAM, C ;
CRITCHLEY, DJP ;
RANCE, DJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (02) :481-490
[10]   METABOLISM OF AMLODIPINE IN THE RAT AND THE DOG - A SPECIES-DIFFERENCE [J].
BERESFORD, AP ;
MACRAE, PV ;
STOPHER, DA .
XENOBIOTICA, 1988, 18 (02) :169-182